首页>
外国专利>
Treatment of multiple sclerosis using COP-1 and Th-2 promoting cytokines
Treatment of multiple sclerosis using COP-1 and Th-2 promoting cytokines
展开▼
机译:使用COP-1和Th-2促进细胞因子治疗多发性硬化症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a treatment for multiple sclerosis. COP-1 (copolymer-1), a synthetic polymer consisting of a mixture of random synthetic polypeptides composed of L-alanine, L-glutamic acid, L-lysine and L-tyrosine in a molar ratio of about 6:2:5:1, is administered mucosally to patients afflicted with the disease in combination with Th2 enhancing cytokines such as IL-4 or IL-10. The combination treatment of IL-4 or IL-10 (preferably orally administered) with mucosally administered COP-1 shows a substantially greater suppressive effect than does treatment with cytokine or COP-1 alone.
展开▼